Swiss National Bank’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
421,500
+11,100
| +3% | +$29.3K | ﹤0.01% | 2099 |
|
|
2025
Q1 | $1.24M | Buy |
410,400
+136,400
| +50% | +$411K | ﹤0.01% | 2038 |
|
|
2024
Q4 | $701K | Buy |
274,000
+4,000
| +1% | +$10.2K | ﹤0.01% | 2342 |
|
|
2024
Q3 | $1M | Buy |
270,000
+6,900
| +3% | +$25.7K | ﹤0.01% | 2216 |
|
|
2024
Q2 | $1.66M | Hold |
263,100
| – | – | ﹤0.01% | 1910 |
|
|
2024
Q1 | $1.41M | Hold |
263,100
| – | – | ﹤0.01% | 2036 |
|
|
2023
Q4 | $1.32M | Sell |
263,100
-21,500
| -8% | -$108K | ﹤0.01% | 2088 |
|
|
2023
Q3 | $481K | Hold |
284,600
| – | – | ﹤0.01% | 2516 |
|
|
2023
Q2 | $791K | Buy |
284,600
+25,400
| +10% | +$70.6K | ﹤0.01% | 2413 |
|
|
2023
Q1 | $472K | Sell |
259,200
-30,800
| -11% | -$56.1K | ﹤0.01% | 2537 |
|
|
2022
Q4 | $1.47M | Buy |
290,000
+8,900
| +3% | +$45.1K | ﹤0.01% | 2089 |
|
|
2022
Q3 | $1.4M | Hold |
281,100
| – | – | ﹤0.01% | 2119 |
|
|
2022
Q2 | $1.05M | Buy |
281,100
+93,100
| +50% | +$346K | ﹤0.01% | 2335 |
|
|
2022
Q1 | $1.06M | Buy |
188,000
+15,900
| +9% | +$89.2K | ﹤0.01% | 2380 |
|
|
2021
Q4 | $1.05M | Buy |
172,100
+2,500
| +1% | +$15.2K | ﹤0.01% | 2455 |
|
|
2021
Q3 | $1.65M | Buy |
169,600
+85,500
| +102% | +$833K | ﹤0.01% | 2170 |
|
|
2021
Q2 | $1.2M | Buy |
84,100
+9,600
| +13% | +$137K | ﹤0.01% | 2396 |
|
|
2021
Q1 | $1.77M | Buy |
74,500
+1,300
| +2% | +$30.9K | ﹤0.01% | 2076 |
|
|
2020
Q4 | $976K | Buy |
+73,200
| New | +$976K | ﹤0.01% | 2296 |
|
|
2017
Q2 | – | Sell |
-42,450
| Closed | -$151K | – | 2565 |
|
|
2017
Q1 | $151K | Hold |
42,450
| – | – | ﹤0.01% | 2523 |
|
|
2016
Q4 | $243K | Hold |
42,450
| – | – | ﹤0.01% | 2535 |
|
|
2016
Q3 | $330K | Hold |
42,450
| – | – | ﹤0.01% | 2465 |
|
|
2016
Q2 | $264K | Buy |
42,450
+6,100
| +17% | +$37.9K | ﹤0.01% | 2531 |
|
|
2016
Q1 | $289K | Buy |
36,350
+6,450
| +22% | +$51.3K | ﹤0.01% | 2502 |
|
|
2015
Q4 | $518K | Buy |
+29,900
| New | +$518K | ﹤0.01% | 2241 |
|